PALO ALTO, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (VINC) (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through ...

Moderna beats Q3 forecasts as cost-cutting offsets weaker COVID vaccine sales and new mRNA cancer trials advance.

Merck has launched a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027, the company said Tuesday in its quarterly report. Merck, which is facing plummeting sales of ...

As more pharma companies launch DTC platforms, marketers will need to develop strategies that take patient experience and transparency into account.

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as ...

This report, published by Towards Healthcare, a sister firm of Precedence Research, provides an in-depth analysis of the global CDMO services market for pharma and biotech. It highlights key growth ...

This report, published by Towards Healthcare, a sister firm of Precedence Research, provides an in-depth analysis of the ...

Merck will reduce its staff by approximately 6,000 in “some areas of our global workforce,” the New Jersey drugmaker told Fierce Pharma. The cuts will affect 8% of the company's headcount. Word of the ...

Newamsterdam Pharma Company N.V. (NAMS) has disclosed a new risk, in the Corporate Activity and Growth category. Newamsterdam Pharma Company N.V. faces significant business risks as it will lose its ...

The pharmaceutical industry is entering a transformative era where Artificial Intelligence in Drug Discovery is rapidly ...